ARID1A and cancer: Its dysfunction can impair immune surveillance, potentially allowing cancer cells to evade immune detection.33 Our results show that ARID1A and B2M mutations are each associated with significant short DFS, with the combined presence of these mutations linked to an even more pronounced decrease in survival, indicating a possible synergistic effect.